Fundraising FoxWu Capital
Series A
Find your way into Wu Capital
Sign up to find every way you can get introduced to Wu Capital
- Your email: who you already know at Wu Capital, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Wu Capital team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
What they invest in
from 8 of 8 portfolio companiesBiotech ×3Enterprise Software ×3Fintech ×3SaaS ×3AI & Machine Learning ×2Crypto & Web3 ×2Healthtech ×2Data & Infrastructure ×1
HQs:China×2United States×2Argentina×1Hong Kong×1
Investments · 8 tracked
founders shown can be your intro pathBy year:2021 · 12020 · 12019 · 12018 · 12017 · 15 dated
Korro Bio is a biotechnology company developing a new class of RNA-editing therapies guided by human genetics and disease biology.
BiotechHealthtechCambridge, US
Nessan Bermingham(Mr. Bermingham is the Executive Chair of the Issuer.)inJean-François Formela(Director)inOmmer Chohan(Mr. Chohan is the Secretary and Treasurer of the Issuer.)inRam Aiyar(Chief Executive Officer, President and Director)inTodd Chappell(Chief Operating Officer)in
Co-investorsAtlas VentureMC Healthcare VenturesNew Enterprise Associates (NEA)AlexandriaQiming Venture Partners USARock Springs Capital+1 more
Laiye offers a Work Execution Platform that lets government and enterprise clients build LLM-driven digital workforces, combining RPA, conversational AI, and intelligent document processing to automate business processes.
AI & Machine LearningEnterprise SoftwareSaaSBeijing, CN
Yichuan Hu(Founder)in
Co-investorsCathay InnovationDCP CapitalLightspeed Venture PartnersSequoia CapitalZhenFundActivant Capital+2 more
Aries offers a trading platform where users can trade individual stocks, ETFs, options, and index options in a single application.
Data & InfrastructureDeveloper ToolsFintechSaaS
RedaPash
Co-investorsID VenturesMichigan RiseShenzhen Capital GroupVision Plus CapitalYunqi Partners
Cobo provides a digital asset custody and wallet platform for institutions such as exchanges, funds, and fintechs, offering custodial, MPC, smart contract, and exchange wallets through unified APIs and SDKs.
Crypto & Web3Enterprise SoftwareFintechHong Kong, HK
Changhao Jiang(Founder)in
Co-investorsBitDAOBN CapitalCyberport Hong KongMantle NetworkA&T CapitalDHVC+3 more
Inipharm is a clinical-stage biopharmaceutical company developing small-molecule inhibitors targeting HSD17B13 to treat severe fibrotic liver diseases, including MASH and other conditions with established genetic validation.
BiotechHealthtechMedical Devices
Brian Farmer(Co-Founder, Chief Executive Officer)inHeather Hsu, PhD(Co-Founder, Chief Scientific Officer)Michael Gallatin, PhD(Co-Founder, SAB Chair)Chuhan Chung(Chief Medical Officer)in
Co-investors5AM VenturesFrazier Life SciencesFrazier Healthcare Partners
Ping is a fintech platform offering free USD accounts and global payment solutions for freelancers and international workers.
Crypto & Web3FintechBuenos Aires, AR
Mary Saracco(Founder)inPablo Orlando(Founder)inJack Saracco(Founder)in
Co-investorsY CombinatorGeneral CatalystGoat CapitalLightspeed Venture PartnersLuminous VenturesSequoia Capital
.png)
Sanjieke is a China-based digital talent training provider that offers online learning platforms and courses to enterprises and individuals for digital transformation and workforce upskilling.
AI & Machine LearningEdTechEnterprise SoftwareSaaSBeijing, CN
后显慧 (Luke Hou)(Founder & CEO)徐财星(Founder)in
Co-investorsOwl VenturesIDG CapitalUdemy
Cambridge, MA biotech developing stem cell-derived islet therapy plus an immune-protective device for type 1 diabetes; acquired by Vertex for $950M.
BiotechCambridge, US
Robert Millman(Executive Officer, Director)
BoardTodd Foley(Executive Officer, Director)inMitch Finer(Director)Stephen Knight(Director)inJim Scopa(Director)William Sahlman(Director)
Co-investorsARCH Venture PartnersF-Prime CapitalJDRF T1D FundORI CapitalSlater Technology Fund6 Dimensions Capital+4 more
Exits · 2
1 IPOs · 1 acquisitionsKorro BioNASDAQ: KRROSemma Therapeuticsacq. by Vertex Pharmaceuticals
Portfolio news
latest coverage across their companiesCobo · cobo.com · May 28, 2026
Frequently asked questions
- How many investments has Wu Capital made?
- Wu Capital has 8 tracked investments, 2 of which have exited.
- What stage does Wu Capital invest at?
- Wu Capital invests at the Series A stage.
Similar investors
3TS Capital Partners is a European technology-focused growth investment adviser whose advised funds provide growth capital, typically leading or co-leading substantial funding rounds for innovative tech companies primarily in the DACH, CEE and Nordic regions.
4DI Ventures was co-founded by repeat tech operator and ESET Southern Africa founder Justin Stanford, giving it unusually deep cybersecurity and software operating experience rather than a purely financial background, and originated from Stanford's own angel-investing experiments that directly led to both the firm's creation and the launch of the Silicon Cape Initiative. The firm explicitly describes its style as "nurture capital" with intensive, hands-on engagement, and Stanford is vocal about avoiding the "unicorn at all costs" mentality in African tech, instead emphasizing sustainable market readiness and fundamentals in a more conservative, durability-focused investment approach.
83North is a global venture capital firm that invests in and helps entrepreneurs build large, category-defining companies, backing startups across multiple stages and sectors.
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.